Avanos Medical (AVNS) Depreciation and Depletion (2013 - 2026)

Avanos Medical has disclosed Depreciation and Depletion across 14 years of filings, most recently posting $5.6 million for Q1 2026.

• Depreciation and Depletion for Q1 2026 came in at $5.6 million, up 24.44% year-over-year; the trailing twelve-month figure through Mar 2026 was $20.8 million (up 6.67% YoY), and the FY2025 annual result was $19.7 million, down 2.96% from the prior year.
• Depreciation and Depletion came in at $5.6 million for Q1 2026 at Avanos Medical, up from $5.4 million in the prior quarter.
• In the past five years, Depreciation and Depletion ranged from a high of $5.6 million in Q1 2026 to a low of $4.2 million in Q4 2022.
• The 5-year median for Depreciation and Depletion is $4.9 million (2023), against an average of $4.9 million.
• Peak annual rise in Depreciation and Depletion reached 500.0% in 2022, while the deepest fall reached 18.52% in 2022.
• Avanos Medical's Depreciation and Depletion stood at $4.2 million in 2022, then rose by 19.05% to $5.0 million in 2023, then fell by 6.0% to $4.7 million in 2024, then grew by 14.89% to $5.4 million in 2025, then rose by 3.7% to $5.6 million in 2026.
• The last three Depreciation and Depletion figures came in at $5.6 million (Q1 2026), $5.4 million (Q4 2025), and $5.0 million (Q3 2025), per Business Quant data.